English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/163297
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorCamacho, Eva María-
dc.contributor.authorMesa-Pereira, Beatriz-
dc.contributor.authorMedina, Carlos-
dc.contributor.authorSantero, Eduardo-
dc.date.accessioned2018-04-09T07:37:41Z-
dc.date.available2018-04-09T07:37:41Z-
dc.date.issued2016-
dc.identifierdoi: 10.1038/srep30591-
dc.identifiere-issn: 2045-2322-
dc.identifier.citationScientific Reports 6: 30591 (2016)-
dc.identifier.urihttp://hdl.handle.net/10261/163297-
dc.description.abstractSalmonella have many desirable properties as antitumour-Agent due to its ability to proliferate inside tumours and induce tumour regression. Additionally, this bacterium can be genetically engineered to deliver therapeutic proteins intratumourally. The main limitation of this approach is the efficient release of therapeutic molecules from intratumoural bacteria. Here we have developed an inducible autolysis system based in the lysis operon of the lambda phage that, in response to anhydrotetracycline, lysates Salmonella thus releasing its content. The system was combined with a salicylate cascade system that allows efficient production of therapeutic molecules in response to aspirin and with a sifA mutation that liberates bacteria from the vacuoles to a cytosolic location. The combination of these three elements makes this strain a putative powerful instrument in cancer treatment. We have used this engineered strain for the intracellular production and delivery of Cp53 peptide. The engineered strain is able to sequentially produce and release the cytotoxic peptide while proliferating inside tumour cells, thus inducing host cell death. Our results show that temporal separation of protein production from protein release is essential to efficiently kill tumour cells. The combined system is a further step in the engineering of more efficient bacteria for cancer therapy.-
dc.description.sponsorshipThis work was supported by the Grant ‘Proyecto de Excelencia P07-CVI02518’ from the Andalusian government and by Spanish Ministry of Science and Innovation grants BIO2014-57545-R. C. M. holds a JAE DOC contract from the Spanish National Research Council (CSIC).-
dc.publisherNature Publishing Group-
dc.relationMINECO/ICTI2013-2016/BIO2014-57545-R-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.titleEngineering Salmonella as intracellular factory for effective killing of tumour cells-
dc.typeartículo-
dc.relation.publisherversionhttps://doi.org/10.1038/srep30591-
dc.date.updated2018-04-09T07:37:41Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/-
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España)-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderJunta de Andalucía-
dc.contributor.funderMinisterio de Ciencia e Innovación (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003339es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004837es_ES
dc.identifier.pmid27464652-
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
engisalmocell.pdf1,2 MBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.